Form 4: Mangoceuticals COO Amanda Hammer Acquires 100,000 Shares of Common Stock

Amanda Hammer, Chief Operating Officer of Mangoceuticals, acquired 100,000 shares of common stock on June 3, 2024, as compensation for services rendered.

Summary

• On June 3, 2024, Amanda Hammer, the Chief Operating Officer of Mangoceuticals, Inc. (MGRX), acquired 100,000 shares of common stock.
• The acquisition was made in consideration for services rendered as Chief Operating Officer.
• The shares were issued under the registrant's Amended and Restated 2022 Equity Incentive Plan and are exempt pursuant to Rule 16b-3.
• Following the transaction, Ms. Hammer beneficially owns 175,000 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by an executive as part of their compensation. It doesn't inherently indicate positive or negative sentiment, but the acquisition could be interpreted as a sign of confidence.

Positives

• The acquisition of shares by the COO could be seen as a positive sign, indicating confidence in the company's future.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the ownership changes of company executives.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment if viewed as a sign of confidence by the COO.

Key Dates

Keywords

Mangoceuticals, MGRX, Amanda Hammer, Chief Operating Officer, stock acquisition, Form 4, beneficial ownership, equity incentive plan